A Review of the Risk of Cutaneous Squamous Cell Carcinoma after Vismodegib Therapy. J of Skin [Internet]. 2022 Nov. 16 [cited 2026 Feb. 1];6(6):453-7. Available from: https://skin.dermsquared.com/skin/article/view/1762